Skip to content

Insider · CIK 0001239757

LANGER ROBERT

Reports to the SEC for 18 companies · REDWOOD CITY, CA

Transactions

50

Companies

18

Filings

11

CIK

0001239757

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2026-07-28SEERSeer, Inc.A Award—
2026-07-28SEERSeer, Inc. · Stock Option (right to buy)A Award—
2025-07-07SEERSeer, Inc. · Stock Option (right to buy)A Award—
2025-07-07SEERSeer, Inc.A Award—
2024-06-12SEERSeer, Inc.A Award—
2024-05-06MRNAModerna, Inc. · Stock Option (Right to Buy)A Award—
2023-06-14SEERSeer, Inc. · Stock Option (right to buy)A Award—
2023-06-14SEERSeer, Inc.A Award—
2023-05-03MRNAModerna, Inc. · Stock Option (Right to Buy)A Award—
2022-08-17KRROKorro Bio, Inc. · Stock OptionA Award—
2022-08-17KRROKorro Bio, Inc. · Stock OptionD Disposition to Issuer—
2022-08-17KRROKorro Bio, Inc. · Stock OptionA Award—
2022-08-17KRROKorro Bio, Inc. · Stock OptionD Disposition to Issuer—
2022-06-21KRROKorro Bio, Inc. · Stock OptionA Award—
2022-06-15SEERSeer, Inc.A Award—
2022-06-15SEERSeer, Inc. · Stock Option (right to buy)A Award—
2022-05-05MRNAModerna, Inc.G Gift—
2022-04-28MRNAModerna, Inc. · Restricted Stock UnitsM Exercise/Conversion—
2022-04-28MRNAModerna, Inc.M Exercise/Conversion—
2022-04-28MRNAModerna, Inc. · Stock Option (Right to Buy)A Award—
2022-01-10SEERSeer, Inc. · Class B Common StockC Conversion—
2022-01-10SEERSeer, Inc.C Conversion—
2021-06-17SEERSeer, Inc. · Stock Option (right to buy)A Award—
2021-06-17KRROKorro Bio, Inc. · Stock OptionA Award—
2021-04-28MRNAModerna, Inc. · Stock Option (Right to Buy)A Award—
2021-04-28MRNAModerna, Inc. · Restricted Stock UnitsA Award—
2020-12-08SEERSeer, Inc. · Series A Convertible Preferred StockC Conversion—
2020-12-08SEERSeer, Inc.C Conversion—
2020-12-03SEERSeer, Inc. · Stock Option (right to buy)A Award—
2020-11-17KRROKorro Bio, Inc.G Gift—
2020-06-11KRROKorro Bio, Inc. · Stock OptionA Award—
2020-05-05LYRALyra Therapeutics, Inc. · Series A-1/A Convertible Preferred StockC Conversion—
2020-05-05LYRALyra Therapeutics, Inc.C Conversion—
2020-04-30LYRALyra Therapeutics, Inc. · Stock OptionA Award—
2020-04-29MRNAModerna, Inc. · Stock Option (Right to Buy)A Award—
2019-10-14Rubius Therapeutics, Inc.S Sale−$63.9K
2019-10-14Rubius Therapeutics, Inc.M Exercise/Conversion+$1,125
2019-10-14Rubius Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion—
2019-07-15Rubius Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion—
2019-07-15Rubius Therapeutics, Inc.S Sale−$112K
2019-07-15Rubius Therapeutics, Inc.M Exercise/Conversion+$1,125
2019-06-27MRNAModerna, Inc. · Stock Option (Right to Buy)A Award—
2019-05-23Rubius Therapeutics, Inc.Stock Option (Right to Buy)A Award—
2019-04-15Rubius Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion—
2019-04-15Rubius Therapeutics, Inc.M Exercise/Conversion+$1,125
2019-04-15Rubius Therapeutics, Inc.S Sale−$132K
2019-01-14Rubius Therapeutics, Inc.S Sale−$109K
2019-01-14Rubius Therapeutics, Inc.M Exercise/Conversion+$1,125
2019-01-14Rubius Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion—
2018-12-11MRNAModerna, Inc. · Series G Preferred StockC Conversion—